Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Semaxanib

Generic Name: Semaxanib

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₁₄N_₂O

CAS Number: 194413-58-6

Unique Ingredient Identifier: 71IA9S35AJ

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in colorectal cancer and lung cancer.

Associated Conditions

No associated conditions information available.

Clinical Trials

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1

Posted: 2004/07/19

Sponsor:Jonsson Comprehensiv...

ID:NCT00005996

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase 2

Completed

Posted: 2004/07/19

Sponsor:

AIDS Malignancy Cons...

ID:NCT00005042

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase 1

Completed

Posted: 2004/06/16

Sponsor:Pfizer

ID:NCT00003720

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Phase 2

Terminated

Posted: 2004/05/26

Sponsor:National Cancer Inst...

ID:NCT00006001

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy

Phase 1

Completed

Posted: 2004/05/26

Sponsor:National Cancer Inst...

ID:NCT00005942

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy